C Pulliam, M Burack, J Giuffrida, T Mera 18th International Congress of Parkinson’s Disease and Movement Disorders, Stockholm, Sweden, 2014
Blog Archives
Motion Sensor Dyskinesia Assessment During Activities of Daily Living
C. Pulliam, M. Burack, J. Giuffrida, T. Mera 66th Annual Meeting Of The American Academy Of Neurology, Philadelphia, PA, 2014
PRESS RELEASE: Great Lakes NeuroTechnologies Continues Intellectual Property Growth As New Patent Claims Focus On Parkinson’s Device Accuracy And Sensitivity
VIEW PRESS RELEASE 05 MAR 2014: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received a new allowance of claims from the U.S. Patent Office, the company’s fourth in the past eight months focused on technology for…
Tagged with: assessment, bradykinesia, clinical trials, company, dbs, deep brain stimulation, development, dyskinesia, gait, growth, kinesia, movement disorders, neuroprotective, parkinson's disease, patent, pd, rigidity, telemedicine, tremor
Objective Motion Sensor Assessment Highly Correlated with Scores of Global Levodopa-Induced Dyskinesia in Parkinson’s Disease
T. Mera, M. Burack, J. Giuffrida J Parkinsons Dis. 2013 Jan 1;3(3):399-407.
Tagged with: assessment, dyskinesia, levodopa, levodopa-induced dyskinesias, motion sensor, parkinson's disease, pd
PRESS RELEASE: GLNT Awarded Patent For Sensor Based Continuous Parkinson’s Assessment During Daily Activities
VIEW PRESS RELEASE [PDF] 03 DEC 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today they have received allowance of claims from the U.S. Patent Office for an application covering their system and method of continuous monitoring of motor…
PRESS RELEASE: GLNT Expanding Telemedicine Technology for Parkinson’s Disease
VIEW PRESS RELEASE [PDF] 05 Sept 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today they are launching commercialization and clinical studies to expand their telemedicine technology, Kinesia HomeView™ [ http://glneurotech.com/kinesia/homeview/ ], for individuals with Parkinson’s disease by…
PRESS RELEASE: Kinesia ProView Launches to Visualize Parkinson’s Symptom Response to Deep Brain Stimulation Programming
VIEW PRESS RELEASE [PDF] 15 MAY 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today the product launch of Kinesia ProView™ [ http://www.glneurotech.com/kinesia/proview/index.php ] to visualize motor symptom severity response during programming of deep brain stimulation (DBS) for Parkinson’s…
PRESS RELEASE: Great Lakes NeuroTechnologies Secures $1.7 Million to Develop Continuous Dyskinesia Monitoring Technology for Parkinson’s Disease
VIEW PRESS RELEASE [PDF] 05 Mar 2013: Valley View, OH – Great Lakes NeuroTechnologies (GLNT) announced today that they are launching commercialization and clinical studies to validate a system for objective, continuous monitoring of dyskinesias associated with Parkinson’s disease. The…
PRESS RELEASE: Great Lakes NeuroTechnologies’ Kinesia Technology Receives TGA Approval for Parkinson’s Assessment in Australia
VIEW PRESS RELEASE [PDF] 9 JAN 2013: Valley View, OH – Great Lakes NeuroTechnologies announced today that they received TGA approval to market Kinesia technology in Australia. The Kinesia™ product line [ http://glneurotech.com/kinesia/ ] includes patient-worn motion sensors and a…
PRESS RELEASE: GLNT Issued Patent Claims For Technology To Assess Parkinson’s Disease
VIEW PRESS RELEASE [PDF] 6 JUN 2012: Valley View, OH – Great Lakes NeuroTechnologies announced today that the U.S. Patent Office has issued claims under patent number 8,187,209 covering their Movement Disorder Monitoring System and Method for quantitative assessment of…